Biotech News

Next-Generation Tablo Hemodialysis System Receives FDA Clearance, Second Quarter Launch Planned

Outset Medical (OM)Outset Medical2026-06-25 13:46 ESTFDA / regulatory

Tablo becomes first dialysis system to clear FDA’s most rigorous cybersecurity standards SAN JOSE, Calif., Jan. 27, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering a first-of-its-kind technology to improve clinical outcomes in dialysis with less

Open original release

Related news

Outset Medical

Outset Medical is a medical devices company focused on product adoption, procedure volume, and how clinical workflow converts into recurring demand.

Recent company news

Stock data

Close
Market cap
Exchange
NASDAQ
Sector
Biotechnology
Location
United States